Assignee
SEPRACOR INC
US320 patents
Top patents by PatentIndex Score
US6458374B1Oct 1, 2002
Methods and compositions for treating chronic disorders using optically pure (+)-bupropion
SEPRACOR INC118 citations99
US6342496B1Jan 29, 2002
Bupropion metabolites and methods of use
SEPRACOR INC217 citations98
US5715810AFeb 10, 1998
Inhalation devices
SEPRACOR INC144 citations98
US7294637B2Nov 13, 2007
Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
SEPRACOR INC89 citations97
US6627646B2Sep 30, 2003
Norastemizole polymorphs
SEPRACOR INC276 citations97
US6472563B1Oct 29, 2002
Formoterol tartrate process and polymorph
SEPRACOR INC78 citations97
US6268533B1Jul 31, 2001
Formoterol process
SEPRACOR INC170 citations97
US6204285B1Mar 20, 2001
Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolate
SEPRACOR INC158 citations97
US5795564AAug 18, 1998
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
SEPRACOR INC106 citations97
US5786357AJul 28, 1998
Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
SEPRACOR INC102 citations97
US7381724B2Jun 3, 2008
Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing same
SEPRACOR INC35 citations96
US7132551B2Nov 7, 2006
Ligands for monoamine receptors and transporters, and methods of use thereof
SEPRACOR INC45 citations96
US7125874B2Oct 24, 2006
Optically active 5H-pyrrolo[3,4-b] pyrazine derivative, its preparation and pharmaceutical compositions containing same
SEPRACOR INC43 citations96
US7087785B2Aug 8, 2006
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
SEPRACOR INC28 citations96
US6992077B2Jan 31, 2006
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
SEPRACOR INC43 citations96
US6864257B2Mar 8, 2005
Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it
SEPRACOR INC45 citations96
US6720453B2Apr 13, 2004
Formoterol tartrate polymorph
SEPRACOR INC34 citations96
US6489341B1Dec 3, 2002
Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
SEPRACOR INC55 citations96
US6476019B1Nov 5, 2002
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
SEPRACOR INC42 citations96
US6444673B1Sep 3, 2002
Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it
SEPRACOR INC71 citations96
US6384038B1May 7, 2002
Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
SEPRACOR INC46 citations96
US6369079B1Apr 9, 2002
Methods for treating irritable bowel syndrome using optically pure (+) norcisapride
SEPRACOR INC58 citations96
US6369113B2Apr 9, 2002
Method for treating depression using optically pure (−)-bupropion
SEPRACOR INC43 citations96
US6342533B1Jan 29, 2002
Derivatives of (−)-venlafaxine and methods of preparing and using the same
SEPRACOR INC44 citations96
US6319926B1Nov 20, 2001
Optically active 5H-pyrrolo[3, 4-B]pyrazine derivative, its preparation and pharmaceutical compositions containing it
SEPRACOR INC70 citations96
US6291490B1Sep 18, 2001
Methods and compositions for treating conditions caused by excessive calcium influx in cells using optically pure (-) amlodipine
SEPRACOR INC47 citations96
US6277887B1Aug 21, 2001
Methods for treating Parkinson's disease using optically pure (−)-bupropion
SEPRACOR INC37 citations96
US6197828B1Mar 6, 2001
Derivatives of (+)-venlafaxine and methods of preparing and using the same
SEPRACOR INC63 citations96
US6184377B1Feb 6, 2001
Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
SEPRACOR INC51 citations96
US6057344AMay 2, 2000
Methods for treating hypertension, and angina using optically pure (-) amlodipine
SEPRACOR INC76 citations96
US6040344AMar 21, 2000
Formoterol process
SEPRACOR INC103 citations96
US5985868ANov 16, 1999
Methods and compositions for treating androgen-dependant diseases using optically pure R-(-) casodex
SEPRACOR INC68 citations96
US5962494AOct 5, 1999
Methods for treating behavioral and other disorders using optically pure R(+) ondansetron
SEPRACOR INC56 citations96
US5736577AApr 7, 1998
Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
SEPRACOR INC56 citations96
US5712302AJan 27, 1998
Compositions using optically pure R(+) ondansetron
SEPRACOR INC37 citations96
US5677346AOct 14, 1997
Treating urinary incontinence using (S)-desethyloxybutynin
SEPRACOR INC61 citations96
US5648396AJul 15, 1997
Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor
SEPRACOR INC56 citations96
US5532278AJul 2, 1996
Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
SEPRACOR INC81 citations96
US5362755ANov 8, 1994
Method for treating asthma using optically pure (R)-albuterol
SEPRACOR INC60 citations96
US5331000AJul 19, 1994
Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
SEPRACOR INC88 citations96
US5268097ADec 7, 1993
Passivated and stabilized porous mineral oxide supports and method for the preparation and use of same
SEPRACOR INC102 citations96
US5258517ANov 2, 1993
Method of preparing optically pure precursors of paroxetine
SEPRACOR INC62 citations96
US5104899AApr 14, 1992
Methods and compositions for treating depression using optically pure fluoxetine
SEPRACOR INC97 citations96
US5077217ADec 31, 1991
Method for membrane reactor resolution of stereoisomers
SEPRACOR INC58 citations96
US5057427AOct 15, 1991
Method for resolution of stereoisomers
SEPRACOR INC64 citations96
US4800162AJan 24, 1989
Method for resolution of steroisomers in multiphase and extractive membrane reactors
SEPRACOR INC78 citations96
US6476078B2Nov 5, 2002
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
SEPRACOR INC43 citations95
US6436936B1Aug 20, 2002
Methods and compositions for treating disorders, using optically pure (+) zopiclone
SEPRACOR INC42 citations95
US6180640B1Jan 30, 2001
Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto
SEPRACOR INC60 citations95
US6068833AMay 30, 2000
Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol
SEPRACOR INC48 citations95
Showing the top 50 of 320 patents by PatentIndex Score.